Infinity Pharmaceuticals
(OTC) INFIQ
Infinity Pharmaceuticals Financials at a Glance
Market Cap
$100
Revenue (TTM)
$2.57M
Net Income (TTM)
$40.95M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
116.07 (High)
Dividend
$0.00
Beta (Volatility)
116.07 (High)
Price
$0.00
Volume
20,010
Open
$0.00
Price
$0.00
Volume
20,010
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
116.07 (High)
Price
$0.00
Volume
20,010
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
INFIQ News
INFIQ: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Infinity Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
30
CEO
Adelene Q. Perkins, MBA
Website
www.infi.comHeadquarters
Cambridge, US
INFIQ Financials
Key Financial Metrics (TTM)
Gross Margin
40%
Operating Margin
-17%
Net Income Margin
-17%
Return on Equity
0%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$100.00
Shares Outstanding
90.76M
Volume
20.01K
Short Interest
0.00%
Avg. Volume
7.12K
Financials (TTM)
Gross Profit
$1.03M
Operating Income
$44.84M
EBITDA
$43.73M
Operating Cash Flow
$42.43M
Capital Expenditure
$17.00K
Free Cash Flow
$42.45M
Cash & ST Invst.
$38.31M
Total Debt
$48.13M
Infinity Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$583.00K
N/A
Gross Profit
$231.00K
N/A
Gross Margin
39.62%
N/A
Market Cap
$100.00
N/A
Market Cap/Employee
$3.33
N/A
Employees
30
N/A
Net Income
$9.96M
N/A
EBITDA
$9.80M
N/A
Quarterly Fundamentals
Net Cash
$17.11M
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$633.00K
N/A
Return on Assets
-1.05%
N/A
Return on Invested Capital
-1.57%
N/A
Free Cash Flow
$8.01M
N/A
Operating Cash Flow
$8.01M
N/A